ROCO
4744
Market cap49mUSD
Oct 08, Last price
28.55TWD
1D
0.35%
1Q
-0.87%
Jan 2017
-21.31%
IPO
18.32%
Name
CVC Technologies Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CVC Technologies Inc. is a global supplier specializing in the production and distribution of a comprehensive array of pharmaceutical packaging machinery. Their extensive product portfolio addresses diverse packaging needs, featuring advanced tablet counting systems such as bottle unscramblers, air rinsers, tablet and capsule counters/fillers, desiccant and cotton/foam inserters, and a variety of cappers (including chuck, rotary, vial, in-line, and vibratory press models). Other offerings in this category include induction cap sealers, shrink bundlers and tunnels, intermittent cartoners, and sophisticated track and trace machines. The company also provides a wide selection of labeling equipment, like top/bottom/side, wrap-around, and front/back labelers, alongside leaflet topserters, shrink sleeve applicators, and specialized labeler inspection systems. For liquid and powder applications, CVC offers integrated solutions, encompassing bottle unscramblers and air rinsers, liquid fillers and cappers, dedicated capping machines, induction capsealers, labeling units, and cartoner/shrink systems. Further product offerings extend to encapsulation machines, aluminum foil sealing devices, and semi-automatic tablet/capsule counters. Auxiliary equipment is also available, comprising items like jet masters, capsule printing machines, paste making systems, gelatin melting tanks, medicine preparation and drying systems, gelatin reclaim systems, and capsule inspection machines. Beyond its machinery, CVC Technologies Inc. delivers a full suite of support services. These include expert packaging line design, factory acceptance testing, technical phone assistance, field service and preventative maintenance, as well as installation, startup, and training programs. Established in 1979, the company is based in Taichung, Taiwan.
Key people
Jingyi Lin
Chairman of the Board · since 2023
Zhengqi Chen
Deputy General Manager-Sales · since 2011
Minglie He
Deputy General Manager-Pharmaceutical Equipment · since 2009
Gonghong Su
Deputy General Manager-Testing Equipment
Xianzhang Yang
General Manager-Pharmaceutical Equipment · since 2000
Jinjia Zhang
Head of Finance, Corporate Governance Officer · since 2023
Zhonghao Kang
Director · since 2014
Fengzhu Shi Guo
Director · since 2017
Director · since 2017
Kaixun Zhang
General Manager, Director · since 2020
Independent Director · since 2023
Yijian Lin
Independent Director · since 2017
Independent Director · since 2017
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||